SUBSCRIBE
SUBSCRIBE

TMX Newsfile

IN THE PRESS
BioMark Provides First-Quarter 2022 Financial Results and Operational Update
August 30, 2022
 · 
5 min read
Drug Development
Hemostemix Announces Phase II Results Plus New Heart Study Demonstrating Statistically Significant Improvement in Ejection Fraction at 4 and 12 Months after ACP-01 Heart Injections
August 30, 2022
 · 
11 min read
Satellos Bioscience Reports Q2 2022 Financials and Operating Results
August 30, 2022
 · 
5 min read
Satellos Bioscience Inc. Announces the Filing of an Amended and Restated Preliminary Prospectus for Proposed Offering of Units
August 30, 2022
 · 
8 min read
Policy
Biospace News Release Request For American Aires Inc.
August 26, 2022
 · 
5 min read
PharmaDrug Advances Psychedelics Pharmaceutical Program Focused on DMT and DMT Analogues
August 25, 2022
 · 
12 min read
Drug Development
Adaptimmune to Host Live, Virtual Event to Review Phase 1 SURPASS Trial Data and Outline Plans for Further Development in SURPASS Family of Trials
August 25, 2022
 · 
2 min read
Drug Development
Awakn Life Sciences Signs Agreement with a Leading Drug Development Company to Deepen IP Moat for Its Lead Program
August 25, 2022
 · 
6 min read
Hemostemix Announces Unit Private Placement--
August 19, 2022
 · 
8 min read
PharmaDrug Successfully Completes Key Milestone to Support cGMP Production of Clinical Lead Candidate PD-001, Its Patented, Orally Available Version of Cepharanthine for Oncology and Infectious Disease
August 19, 2022
 · 
18 min read
Load More
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us